Skip to main content

Nuria Fernández Hidalgo

Institutions of which they are part

Infectious Diseases
Vall Hebron Institut de Recerca

Nuria Fernández Hidalgo

Institutions of which they are part

Infectious Diseases
Vall Hebron Institut de Recerca

Projects

COVID-19, PERFIL INMUNOLÓGICO DE RIESGO

IP: Ricardo Pujol Borrell
Collaborators: Manuel Hernández González, Mónica Martínez Gallo, Moisés Labrador Horrillo, Gema Codina Grau, Albert Blanco Grau, Andres Antón Pagarolas, Antonio Álvarez Fernandez, Nuria Fernández Hidalgo, Roser Ferrer Costa, Esteve Ribera Pascuet, Juan Carlos Ruiz Rodriguez, Jaume Ferrer Sancho, Anna Suy Franch, Pere Soler Palacín, Albert Selva O'Callaghan, Tomàs Pumarola Suñé, Isabel Ruiz Camps, Marta Miarons Font, Daniel Alvarez De la Sierra, Andrea Martín Nalda, Eva Polverino, Romina Dieli Crimi, Romina Dieli Crimi
Funding agency: Instituto de Salud Carlos III
Funding: 229000
Reference: COV20/00416
Duration: 08/05/2020 - 08/11/2021

Incorporació Dr. Benito Almirante a la RETICS en malalties infeccioses RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSAS

IP: Benito Almirante Gragera
Collaborators: María Nieves Larrosa Escartin, Oscar Len Abad, Judit Serra Pladevall, Gema Codina Grau, Mª Carmen Ferrer Barberà, Andres Antón Pagarolas, Rosa María Bartolomé Comas, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juliana Esperalba Esquerra, Ma Dolores Rodríguez Pardo, Alba Mir Cros, Laura Escola Verge, Julia Sellares Nadal, Tomàs Pumarola Suñé, Carles Pigrau Serrallach, Isabel Ruiz Camps, Mayli Lung Suarez, Mª Teresa Tórtola Fernández, Juan Jose Gonzalez Lopez, Pablo Salvador Corona Pérez-Cardona, Ibai Los Arcos Bertiz, Ester Marquez Algaba
Funding agency: Instituto de Salud Carlos III
Funding: 401918
Reference: RD16/0016/0003
Duration: 01/01/2017 - 31/12/2022

Expresión global génica de cepas de S. aureus sensible a meticilina, causantes de BRC o EI, y su relación con la actividad de antimicrobianos sobre modelos experimentales

IP: Benito Almirante Gragera
Collaborators: María Nieves Larrosa Escartin, Nuria Fernández Hidalgo
Funding agency: Instituto de Salud Carlos III
Funding: 98615
Reference: PI15/02125
Duration: 01/01/2016 - 31/12/2019

Malalties Infeccioses (GRC)

IP: Benito Almirante Gragera
Collaborators: Adria Curran Fàbregas, Oscar Len Abad, Manuel Crespo Casal, Inmaculada Ocaña Rivera, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Esteve Ribera Pascuet, Ma Dolores Rodríguez Pardo, Israel Molina Romero, Fernando M Salvador Velez, Carles Pigrau Serrallach, Isabel Ruiz Camps, Jordi Navarro Mercadé, Joaquin Burgos Cibrian, Adrián Sánchez Montalvá
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 759
Duration: 01/01/2014 - 31/12/2016

Related news

The new protocol has the same efficacy as the standard one, but only a quarter of the duration, reducing dropout rates and side effects.

The initiative, carried out at the Consulate of Bolivia, has resulted in 307 new tests for the diagnosis of Chagas disease

The study shows that blocking the KLRG1 receptor helps to recover the activity of the natural killer cells of the immune system and reactivate the virus reservoir to fight infection.

Related professionals

Stefan Huemmer

Stefan Huemmer

Main researcher
Translational Molecular Pathology
Read more
Manuel López Paredes

Manuel López Paredes

Head of group
Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Ivana Andrea Pribac

Ivana Andrea Pribac

Medium Grade Technician
Tenders and Procurement Unit
Finances Area
Read more
Kathleen Ramirez Tucas

Kathleen Ramirez Tucas

Predoctoral researcher
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.